Variant · Snv
TP53 NM_000546.6(TP53):c.711G>T (p.Met237Ile)
CI-VAR-00113554Explore in graph →p.Met237IleNM_000546.6:c.711G>TClinVar 634770 rs587782664
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 634770 | Pathogenic/Likely pathogenic | criteria provided, multiple submitters, no conflicts | 2 | Ovarian neoplasm; Hereditary cancer-predisposing syndrome; Malignant tumor of urinary bladder; Adrenocortical carcinoma, hereditary; Li-Fraumeni syndrome; Primary intracranial sarcoma, DICER1-mutant; Medulloblastoma SHH activated and TP53 mutant | germline/somatic | 7 | Nov 18, 2025 | clinvar |